Lysergic acid diethylamide (LSD), colloquially known as acid, is a semisynthetic psychedelic compound belonging to the lysergamide family. Derived from ergotamine, a natural alkaloid produced by the fungus Claviceps purpurea, LSD is one of the most potent psychoactive substances known — active at microgram doses as low as 20–25 μg. It produces profound alterations in consciousness, perception, and cognition through primarily serotonergic mechanisms, and has been the subject of both intense scientific research and sweeping cultural influence since its accidental discovery in 1943.
LSD exerts its primary effects through partial agonism at serotonin 5-HT2A receptors in the prefrontal cortex, triggering a cascade of altered thalamocortical signaling that disrupts the brain's normal top-down filtering of sensory information. The result is an expanded perceptual field — enhanced color saturation, geometric visual phenomena, synaesthesia, and a dissolution of the boundaries between self and environment. Cognitively, LSD accelerates associative thinking, intensifies emotional responses, and in higher doses can produce complete ego dissolution — a temporary loss of the sense of individual identity that users frequently describe as both terrifying and profoundly illuminating. Community experience consistently emphasizes that set (mindset) and setting (environment) are the dominant determinants of whether an LSD experience is therapeutic or distressing.
LSD became a cultural flashpoint in the 1960s counterculture, closely associated with the civil rights movement, anti-war activism, and the emergence of a generation that questioned consensus reality. Early research at institutions like Harvard and the Menninger Clinic showed promise for psychotherapy applications before prohibition halted clinical work. Following decades of suppression, a research renaissance beginning in the 2000s has re-established LSD as a serious candidate for treating anxiety, depression, addiction, and cluster headaches. The compound is currently classified as Schedule I in the United States, though multiple jurisdictions have moved toward decriminalization and therapeutic legalization frameworks.
Despite its fearsome reputation in mainstream culture, LSD has a remarkably low acute toxicity profile — no confirmed human fatality from pharmacological action alone has ever been documented. The primary risks are psychological: acute anxiety or panic ("bad trips"), impaired judgment leading to accidents, and in rare cases lasting perceptual disturbances (HPPD). These risks are substantially mitigated by careful dose selection, a trustworthy set and setting, a sober trip sitter, and avoiding combination with other substances.
